CELLECTAR BIOSCIENCES INC's ticker is CLRB and the CUSIP is 15117F500. A total of 41 filers reported holding CELLECTAR BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $708,000 | -41.3% | 1,753,800 | 0.0% | 0.00% | – |
| Q1 2022 | $1,206,000 | -7.4% | 1,753,800 | -10.6% | 0.00% | – |
| Q4 2021 | $1,302,000 | -28.3% | 1,961,305 | -0.1% | 0.00% | – |
| Q3 2021 | $1,817,000 | -18.5% | 1,964,210 | +4.8% | 0.00% | – |
| Q2 2021 | $2,230,000 | -15.7% | 1,874,584 | +14.1% | 0.00% | – |
| Q1 2021 | $2,645,000 | -16.0% | 1,643,404 | +8.6% | 0.00% | – |
| Q4 2020 | $3,149,000 | +3478.4% | 1,513,532 | +2036.6% | 0.00% | – |
| Q3 2020 | $88,000 | +319.0% | 70,837 | +322.8% | 0.00% | – |
| Q2 2020 | $21,000 | -4.5% | 16,755 | 0.0% | 0.00% | – |
| Q1 2020 | $22,000 | -42.1% | 16,755 | 0.0% | 0.00% | – |
| Q4 2019 | $38,000 | +11.8% | 16,755 | 0.0% | 0.00% | – |
| Q3 2019 | $34,000 | -8.1% | 16,755 | 0.0% | 0.00% | – |
| Q2 2019 | $37,000 | -5.1% | 16,755 | 0.0% | 0.00% | – |
| Q1 2019 | $39,000 | +50.0% | 16,755 | 0.0% | 0.00% | – |
| Q4 2018 | $26,000 | -48.0% | 16,755 | 0.0% | 0.00% | – |
| Q3 2018 | $50,000 | – | 16,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,772,848 | $3,688,000 | 2.14% |
| Sio Capital Management, LLC | 2,331,123 | $4,849,000 | 0.99% |
| Consonance Capital Management LP | 4,074,074 | $8,474,000 | 0.79% |
| Altium Capital Management LP | 851,852 | $1,772,000 | 0.66% |
| Tri Locum Partners LP | 658,373 | $1,369,000 | 0.50% |
| Maven Securities LTD | 1,725,000 | $3,709,000 | 0.37% |
| SABBY MANAGEMENT, LLC | 499,030 | $1,038,000 | 0.20% |
| FNY Investment Advisers, LLC | 220,321 | $458,000 | 0.12% |
| 683 Capital Management, LLC | 925,925 | $1,926,000 | 0.09% |
| Boxer Capital, LLC | 920,000 | $1,914,000 | 0.06% |